Abstract:We describe the development of a fully automatic and programmable microfluidic cell culture array that integrates on-chip generation of drug concentrations and pair-wise combinations with parallel culture of cells for drug candidate screening applications. The device has 64 individually addressable cell culture chambers in which cells can be cultured and exposed either sequentially or simultaneously to 64 pair-wise concentration combinations of two drugs. For sequential exposure, a simple microfluidic diffusive mixer is used to generate different concentrations of drugs from two inputs. For generation of 64 pair-wise combinations from two drug inputs, a novel time dependent variable concentration scheme is used in conjunction with the simple diffusive mixer to generate the desired combinations without the need for complex multi-layer structures or continuous medium perfusion. The generation of drug combinations and exposure to specific cell culture chambers are controlled using a LabVIEW interface capable of automatically running a multi-day drug screening experiment. Our cell array does not require continuous perfusion for keeping cells exposed to concentration gradients, minimizing the amount of drug used per experiment, and cells cultured in the chamber are not exposed to significant shear stress continuously. The utility of this platform is demonstrated for inducing loss of viability of PC3 prostate cancer cells using combinations of either doxorubicin or mitoxantrone with TRAIL (TNF-alpha Related Apoptosis Inducing Ligand) either in a sequential or simultaneous format. Our results demonstrate that the device can capture the synergy between different sensitizer drugs and TRAIL and demonstrate the potential of the microfluidic cell array for screening and optimizing combinatorial drug treatments for cancer therapy.

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Microfluidic-Enabled Print-to-Screen Platform for High-Throughput Screening of Combinatorial Chemotherapy

3D Printed Microfluidic Chip for Multiple Anticancer Drug Combinations

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

An On-Chip Cell Culturing and Combinatorial Drug Screening System

A Microfluidic Droplet Array System for Cell-Based Drug Combination Screening

Application of microfluidic chips in anticancer drug screening

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

Selectively cross-linked hydrogel-based cocktail drug delivery micro-chip for colon cancer combinatorial drug screening using AI-CSR platform for precision medicine

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

A Plug-and-Play, Drug-on-Pillar Platform for Combination Drug Screening Implemented by Microfluidic Adaptive Printing

A Programmable Microfluidic Cell Array for Combinatorial Drug Screening.

Large-Scale Antitumor Screening Based on Heterotypic 3D Tumors Using an Integrated Microfluidic Platform.

A UV-sensitive Hydrogel Based Combinatory Drug Delivery Chip (UV Gel-Drug Chip) for Cancer Cocktail Drug Screening

High Throughput Confined Migration Microfluidic Device for Drug Screening (Small 16/2023)

Cocktail Drug Delivery Chip for Cancer Drug Screening

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation

An Integrated Microfluidic 3D Tumor System for Parallel and High-Throughput Chemotherapy Evaluation

Tumor Microenvironment Based on Extracellular Matrix Hydrogels for On-Chip Drug Screening